黄山胶囊收盘上涨1.32%，滚动市盈率39.17倍，总市值20.67亿元

Core Viewpoint - Huangshan Capsule's stock closed at 6.91 yuan on May 6, with a PE ratio of 39.17, marking a new low in 91 days, and a total market value of 2.067 billion yuan [1] Company Overview - Anhui Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules [1] - The company is one of the earliest manufacturers of pharmaceutical hollow capsules in China, with over 30 years of high-quality production history [1] - Huangshan Capsule has a high reputation in the pharmaceutical hollow capsule industry and is a member of the China Pharmaceutical Packaging Association [1] Financial Performance - In Q1 2025, the company achieved an operating income of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, a year-on-year increase of 22.90% [2] - The sales gross margin for the same period was 29.26% [2] Market Position - Huangshan Capsule ranks 79th in the industry based on its PE ratio of 39.17, while the industry average is 48.90 and the median is 36.41 [2] - The company's market value is 2.067 billion yuan, compared to the industry average market value of 10.378 billion yuan [2] Product Recognition - The company's trademark is recognized as a famous trademark in Anhui Province, and its "Jingchuan" brand hollow capsules have received the "Anhui Famous Product" title [1] - The "Jingchuan" brand gelatin hollow capsules and enteric-coated gelatin hollow capsules have been awarded as "Excellent Product Brands" in the pharmaceutical excipients sector of the Chinese chemical pharmaceutical industry [1]